Advertisement
Advertisement
U.S. markets open in 5 hours 4 minutes
Advertisement
Advertisement
Advertisement
Advertisement

Protagenic Therapeutics, Inc. (PTIX)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
0.6885-0.0055 (-0.79%)
At close: 04:00PM EDT
0.6940 +0.01 (+0.80%)
After hours: 07:59PM EDT
Advertisement
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bullishpattern detected
Williams %R

Williams %R

Previous Close0.6940
Open0.7000
Bid0.0000 x 900
Ask0.0000 x 900
Day's Range0.6653 - 0.7099
52 Week Range0.5610 - 2.3500
Volume16,105
Avg. Volume25,069
Market Cap11.674M
Beta (5Y Monthly)-0.19
PE Ratio (TTM)N/A
EPS (TTM)-0.2850
Earnings DateNov 16, 2021
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Overvalued

Subscribe to Yahoo Finance Plus to view Fair Value for PTIX

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • Protagenic Therapeutics, Inc.
    Analyst Report: Akamai Technologies, Inc.Akamai operates a content delivery network, or CDN, which entails locating servers at the edges of networks so its customers, which store content on Akamai servers, can reach their own customers faster, more securely, and with better quality. Akamai has over 325,000 servers distributed over 4,000 points of presence in more than 1,000 cities worldwide. Its customers generally include media companies, which stream video content or make video games available for download, and other enterprises that run interactive or high-traffic websites, such as e-commerce firms and financial institutions. Akamai also has a significant security business, which is integrated with its core web and media businesses to protect its customers from cyberthreats.
    Rating
    Fair Value
    Economic Moat
    7 days agoMorningstar
View more
  • ACCESSWIRE

    Protagenic Therapeutics to Present at the B. Riley Securities Neuro and Ophthalmology Virtual Investor Conference on April 27th

    NEW YORK, NY / ACCESSWIRE / April 26, 2022 / Protagenic Therapeutics, Inc. (NASDAQ:PTIX) a biopharmaceutical company focused on developing drug product candidates to treat stress-related neurologic disorders, today announced will be presenting at the B.

  • GlobeNewswire

    Protagenic Therapeutics Announces Third Quarter 2021 Results and Business Update

    NEW YORK, Nov. 16, 2021 (GLOBE NEWSWIRE) -- Protagenic Therapeutics, Inc. (Nasdaq: PTIX) a biopharmaceutical company focused on developing therapies to treat stress-related neurologic disorders, today announced results for the third quarter ended September 30, 2021. Recent Highlights Hosted a virtual science review to discuss the scientific rationale and evidence for PT00114 in the treatment of Depression, Anxiety, PTSD and Addiction. Replay available at www.protagenic.com.Hosted a key opinion l

  • GlobeNewswire

    Protagenic Therapeutics to Host Virtual Science Review Wednesday, September 8th at 10 AM ET

    Scientific rationale and evidence for PT00114 in the treatment of Depression, Anxiety, PTSD and Addiction to be discussed NEW YORK, Aug. 30, 2021 (GLOBE NEWSWIRE) -- Protagenic Therapeutics, Inc. (Nasdaq: PTIX) a biopharmaceutical company focused on developing therapies to treat stress-related neurologic disorders, today announced that it will host a Scientific review of its programs designed for the treatment of patients with Depression, PTSD, Anxiety and Addiction. The review will take place o

Advertisement
Advertisement